Open AccessHematopoietic stem cell transplant in peru: experience and challenges of the largest transplant center in Perú
Author(s) -
Lourdes Aranda-Gomero,
Rafael Pichardo-Rodríguez,
Iván Fernandez-Vertíz,
Alfredo Wong-Chang
Publication year - 2022
Publication title -
revista de la facultad de medicina humana
Language(s) - English
Resource type - Journals
eISSN - 2308-0531
pISSN - 1814-5469
DOI - 10.25176/rfmh.v22i2.4786
Subject(s) - bone marrow transplant , stem cell , bone marrow , hematopoietic stem cell , hematopoietic stem cell transplantation , human leukocyte antigen , haematopoiesis , medicine , bone marrow transplantation , dysfunctional family , transplantation , immunology , oncology , biology , antigen , genetics , clinical psychology
Bone marrow transplantation, currently known as hematopoietic stem cell transplant (HSCT), involves the infusion of stem cells healthy hematopoietic cells to patients with dysfunctional bone marrow, diminished or compromised by hematological neoplasms. Since its rst exploration in humans in the 1950s based on the results obtained in animal models, more than one million procedures have now been performed in Europe and collaborating countries. Early detection of complications and histocompatibility typing (HLA) with which potential donors can be better-selected thanks to an international donor registry network of bone marrow and the advancement of technology in terms of support treatment.